Bigfinite, the US-based developer of a big data analytics platform for pharmaceutical companies, has received $8.5m in seed funding from investors including industrial process manufacturer Krohne.
The round was co-led by venture capital firms Crosslink Capital and Uncork Capital and VC fund La Famiglia, and backed by VC firm Industry Ventures.
Founded in 2013, Bigfinite has created an analytics software platform that collates pharmaceuticals data for purposes such as real-time monitoring and quality control. A recent update to the platform introduced features such as causality and energy efficiency assessments.
The cash will be used to ramp up Bigfinite’s customer support division as it aims to double its size by the second quarter of 2018. Andy McLoughlin, partner at Uncork Capital, will take a seat on its board of directors.
Bigfinite had previously raised $1.15m in convertible debt financing in July 2016, according to a regulatory filing.